skin breakdown
Medications
SN instructed patient and caregiver on side effects of amoxicillin/clavulanate. Along with its needed effects, amoxicillin/clavulanate may cause some unwanted effects. Call your doctor immediately if any of the following side effects occur: hives or welts, itching, redness of the skin
, skin
rash, thick. Understanding was verbalized.
Educated patient on side effects of macrobid. Some of the side effects include: changes in facial skin
color, general feeling of discomfort or illness, hives, itching, skin
rash, sudden trouble in swallowing or breathing., swelling of the face, mouth, hands, or feet and troubled breathing. Understanding was verbalized.
Instructed patient on medication Amiodarone. This medication is used to stabilize the rhythm of your heart. Amiodarone is used to treat ventricular tachycardia or ventricular fibrillation. Take this medication at the same time daily as directed. May take with or without food. Avoid grapefruit, St. John's wort, & sunlight or tanning beds. common side effects include: nausea, vomiting, loss of appetite; or constipation. Call your doctor or get medical help at once if you have: chest pain, fast or pounding heartbeats, trouble breathing, vision problems, upper stomach pain, vomiting, dark urine, jaundice (yellowing of the skin
or eyes), or if you cough up blood. Tell your doctor if you have signs of a thyroid problem, such as weight changes, extreme tiredness, dry skin
, thinning hair, feeling too hot or too cold, irregular menstrual periods, or swelling in your neck (goiter).
Instructed in new medication Sulfaprim and in S/E such as headache, mental depression, aseptic meningitis, tinnitus, apathy, seizures, hallucinations, ataxia, nervousness, fatigue, vertigo, insomnia, thrombophlebitis, nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis, pancreatitis, pseudomembranous colitis, toxic nephrosis with oliguria and anuria, crystalluria, hematuria, interstitial nephritis, agranulocytosis, aplastic anemia, megaloblastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, jaundice, hepatic necrosis, arthralgia, myalgia, muscle weakness, pulmonary infiltrates, erythema multiforme, Stevens-Johnson syndrome, generalized skin
eruption, toxic epidermal necrolysis, exfoliative dermatitis, photosensitivity, urticaria, pruritus, hypersensitivity reactions, serum sickness, drug fever and anaphylaxis.
Instructed in new medication Prevacid and in S/E such as headache, dizziness, vertigo, malaise, paresthesia, fever, palpitations, flushing, orbital edema, tinnitus, diarrhea, constipation, anorexia, taste perversion, dry mouth, bone and muscle pain, acne, dry skin
and transient irritation at I.V. site.
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin
eruptions.
Instructed in new medication Augmentin to manage infection. In addition, warned of possible S/E such as nausea, vomiting, headache, dizziness, skin
rash, blurred vision, confusion, anxiety, redness, etc.
Instructed in S/E of oxygen therapy such as respiratory depression, collapse lung, irritation of airway mucosa, oxygen toxicity, local skin
irritation.
Instructed in new medication Synthroid and in S/E such as nervousness, insomnia, tremor, headache, fever, tachycardia, palpitations, arrhythmias, angina pectoris, cardiac arrest, diarrhea, vomiting, menstrual irregularities, weight loss, allergic skin
reactions, diaphoresis or heat intolerance.
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin
products on treated area.